Trending...
- Enable Accessible Haircare Wins Bronze at 2025 NACD Packaging Awards
- CoreIntegrator Announces Sage Intacct Approved A/P One Integration, Becoming an Official Sage Partner
- Cooking with the Godfather Blends Family Tradition, Italian Flavor, and Leadership Wisdom
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports.
TEMECULA, Calif. - ncarol.com -- Jellyfish Publication-Certified Nutraceuticals, Inc.
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on ncarol.com
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on ncarol.com
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on ncarol.com
- JU Miner Launches Free Mining: Bitcoin, Dogecoin, and Litecoin
- Zareef Hamid on the Rise of AI-Native Organizations
- Zareef Hamid on Real-Time, Unified Payment Systems Driving the Global Economy
- A World First: The Global Naturism & Nudism Index Launched by NaturismRE™
- Garage Door Scam Alert: Superior Overhead Doors Warns Tulsa Homeowners About Red Flags
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on ncarol.com
- From Surviving to Thriving: Marquette's Destiny Foundation Launches to Empower Raleigh's Most Vulnerable
- Soulful Sounds Co-Owner Launches Holistic Wellness Nonprofit Event June 7th in Charlotte
- Coinbase recommends using Winner Mining Classic hashrate for the benefit of everyone
- Nieves Ministries Leads with Faith to Fortify Safety, Education, and Puerto Rican Culture in Colorado
- Deadline Extended: More Time to Submit Your Proposal for the OpenSSL Conference 2025
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Source: Certified Nutraceuticals, Inc.
0 Comments
Latest on ncarol.com
- June Is Men's Health Month 2025:
- Velocity Performance Alliance Shifts Into High Gear with Luxury Auto Real Estate Platform Ahead of NASCAR Debut
- Floating Water Ramp for Pups is Still Making a Splash
- Bestselling Author Launches Book to Help Men Reclaim Their Power—Just in Time for Father's Day
- Castelletto Homes & International Garden Expert Introduce Edible Kitchen Gardens as New Home Feature
- UIFCA Wealth Academy's Revolutionary UIFCA(UFCA) Token Gains Momentum in AI-Powered Investment Market
- New Website Launch Positions TekTone Builders As Tulsa's Commercial Construction Leader
- Inframark Expands Its Capabilities and Presence in Arizona, Adding Wastewater Experts Mehall Contracting
- FilmHedge Is Letting A.I. Into the Deal Room—And Hollywood Will Never Be the Same
- This Artificial Intelligence Platform Could Change How Hollywood Gets Funded Forever
- $100 Million Financing Unlocked for Aggressive Acquisition and Growth Strategy Including Plan to Acquire Remote Lottery Platform: Stock Symbol: LTRY
- ARCH Dental + Aesthetics Unveils New Website for Enhanced Patient Experience
- Juventix Regenerative Medical Announces Strategic Partnership with Juvasonic® to Expand Needle-Free Biologic Delivery Platform
- Prymax Media & Technology Group Acquires 'Hidden Treasures' From Estate of Jewel Records Founder Stan Lewis
- Dalton Education Partners with Wake Forest University to Offer Accredited Certified Military Financial Advisor Certification
- Cooking with the Godfather Blends Family Tradition, Italian Flavor, and Leadership Wisdom
- Group Seeks End to Mandated Community Psychiatric Programs, Citing Global Alarm
- CoreIntegrator Announces Sage Intacct Approved A/P One Integration, Becoming an Official Sage Partner
- GENIUS EDGE DEFI™ Distributed Energy Flexible Infrastructure
- Enable Accessible Haircare Wins Bronze at 2025 NACD Packaging Awards